1. Home
  2. GPRO vs IMRX Comparison

GPRO vs IMRX Comparison

Compare GPRO & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoPro Inc.

GPRO

GoPro Inc.

HOLD

Current Price

$1.73

Market Cap

282.4M

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$6.10

Market Cap

232.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPRO
IMRX
Founded
2004
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
282.4M
232.9M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
GPRO
IMRX
Price
$1.73
$6.10
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$17.20
AVG Volume (30 Days)
3.3M
835.3K
Earning Date
11-06-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$650,751,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.40
$1.10
52 Week High
$3.05
$10.08

Technical Indicators

Market Signals
Indicator
GPRO
IMRX
Relative Strength Index (RSI) 49.57 40.95
Support Level $1.70 $5.93
Resistance Level $1.92 $6.54
Average True Range (ATR) 0.11 0.37
MACD 0.02 -0.13
Stochastic Oscillator 58.53 15.30

Price Performance

Historical Comparison
GPRO
IMRX

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: